Nick Leschly
2014 - bluebird bio
In 2014, Nick Leschly earned a total compensation of $3.6M as Chief Executive Officer at bluebird bio, a 46% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $303,875 |
|---|---|
| Option Awards | $2,875,111 |
| Salary | $440,404 |
| Total | $3,619,390 |
Leschly received $2.9M in option awards, accounting for 79% of the total pay in 2014.
Leschly also received $303.9K in non-equity incentive plan and $440.4K in salary.
Rankings
In 2014, Nick Leschly's compensation ranked 2,413th out of 13,032 executives tracked by ExecPay. In other words, Leschly earned more than 81.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,413 out of 13,032 | 82nd |
Division Manufacturing | 857 out of 4,967 | 83rd |
Major group Chemicals And Allied Products | 263 out of 1,690 | 84th |
Industry group Drugs | 203 out of 1,369 | 85th |
Industry Biological Products, Except Diagnostic Substances | 33 out of 241 | 86th |
Source: SEC filing on April 21, 2017.
Leschly's colleagues
We found five more compensation records of executives who worked with Nick Leschly at bluebird bio in 2014.
News
2seventy bio CEO Nick Leschly's 2023 pay jumps 49% to $9.1M
5 hours ago
bluebird bio CEO Andrew Obenshain receives $9.3M in 2021
May 2, 2022
2seventy bio CEO Nick Leschly's 2021 pay rises 1% to $6.3M
April 26, 2022
bluebird bio CEO Nick Leschly's 2019 pay falls 45% to $13M
April 27, 2020
bluebird bio CEO Nick Leschly's 2018 pay jumps 173% to $24M
April 23, 2019